Novel selective human melanocortin-3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffold.

MLA

Ballet, Steven, et al. “Novel Selective Human Melanocortin-3 Receptor Ligands: Use of the 4-Amino-1,2,4,5-Tetrahydro-2-Benzazepin-3-One (Aba) Scaffold.” Bioorganic & Medicinal Chemistry Letters, vol. 17, no. 9, May 2007, pp. 2492–98. EBSCOhost, https://doi.org/10.1016/j.bmcl.2007.02.020.

APA

Ballet, S., Mayorov, A. V., Cai, M., Tymecka, D., Chandler, K. B., Palmer, E. S., Rompaey, K. V., Misicka, A., Tourwé, D., & Hruby, V. J. (2007). Novel selective human melanocortin-3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffold. Bioorganic & Medicinal Chemistry Letters, 17(9), 2492–2498. https://doi.org/10.1016/j.bmcl.2007.02.020

Chicago

Ballet, Steven, Alexander V Mayorov, Minying Cai, Dagmara Tymecka, Kevin B Chandler, Erin S Palmer, Karolien Van Rompaey, Aleksandra Misicka, Dirk Tourwé, and Victor J Hruby. 2007. “Novel Selective Human Melanocortin-3 Receptor Ligands: Use of the 4-Amino-1,2,4,5-Tetrahydro-2-Benzazepin-3-One (Aba) Scaffold.” Bioorganic & Medicinal Chemistry Letters 17 (9): 2492–98. doi:10.1016/j.bmcl.2007.02.020.